CABB

Name

CABB

Legal name

CABB Group GmbH

Website

https://cabb-chemicals.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Custom Fine Chemicals Manufacturing (CDMO)

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Other Chemical Product and Preparation Manufacturing (3259)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Custom chemical manufacturing
• Fine chemicals production
• Agrochemical CDMO services
• Specialty chemical synthesis
• Pharmaceutical intermediates manufacturing

Headquarters

HQ city

Sulzbach

HQ country

Germany

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Custom Manufacturing Services: CABB provides custom manufacturing services for complex, multi-step chemical synthesis. They work closely with customers to develop and optimize individual steps in their value chain for synthesis of agrochemicals, pharmaceuticals and other complex patented chemical products. Services include exclusivity arrangements, timely project assessments, full launch capability with multi-disciplinary start-up teams, on-site lab and analytical teams, sustainability-optimized production campaigns, supply chain security, campaign management, experienced audit teams, finance options, and cost-sharing programs.
2. Fine Chemicals Portfolio Products: CABB offers a select portfolio of fine chemicals including acid chlorides, DeTrityl Ultrapure (DCA), GLYCOS Clear 70 glycolic acid, monochloroacetic acid and derivatives, and reagents. Products are sold on a made-to-order or made-to-demand basis combining manufacturing expertise with collaborative sourcing partners. Includes products like GLYCOS Clear 70 premium-grade glycolic acid and DeTrityl Ultrapure dichloroacetic acid.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

CABB Group is a privately held Contract Development and Manufacturing Organization (CDMO) that produces fine chemicals and customized complex molecules through multi-step chemical synthesis for agrochemical, life sciences and performance materials customers. The company operates five integrated production sites in Europe and Asia, offering both custom manufacturing services and a portfolio of branded fine chemical products such as DeTrityl Ultrapure (DCA), GLYCOS Clear 70 glycolic acid, monochloroacetic acid and derivatives, and acid chlorides.

Differentiator

Problem solved

Functional benefit

Brands

• GLYCOS® Clear 70: Premium grade glycolic acid for superior skin- and haircare products
• DeTrityl® Ultrapure
• GLYTECH® Basic 70

Products and services

• Custom Manufacturing Services End-to-end contract development and manufacturing of complex, multi-step fine chemicals for agrochemical, pharmaceutical and specialty chemical customers, including exclusivity arrangements, project assessment, full launch capability with multi-disciplinary start-up teams, on-site lab and analytical support, sustainability-optimized campaigns, supply chain security, campaign management, audit support and cost-sharing programs.
• DeTrityl Ultrapure (Dichloroacetic Acid) Premium-grade dichloroacetic acid (DCA) with >99.2% assay and low chloral hydrate content for high-yield oligonucleotide synthesis and other life-sciences applications; manufactured at two independent sites in Germany (Gersthofen) and Switzerland (Pratteln) to ensure supply security, drawing on more than 50 years of CABB DCA experience.
• GLYCOS Clear 70 (Glycolic Acid) Premium-grade 70% glycolic acid for superior skin- and haircare applications, manufactured via CABB's proprietary MAA-free synthesis route compliant with European Cosmetics Regulation EC 1223/2009; MAA-free, readily biodegradable, exempt from VOCs, non-flammable and REACH-registered.
• GLYTECH Basic 70 (Glycolic Acid) Industrial-grade glycolic acid product distributed in EMEA through CABB's exclusive partnership with Univar Solutions for personal care, home care and industrial cleaning applications across 32 countries.
• Monochloroacetic Acid (MCA) and Derivatives Monochloroacetic acid and downstream derivatives including sodium monochloroacetate (SMCA), produced at some of the world's largest and most efficient plants at Knapsack (Germany), Gersthofen (Germany) and Jining (China), serving crop sciences, life sciences and performance materials customers.
• Acid Chlorides Range of acid chloride intermediates produced by CABB for use in custom synthesis, agrochemical and life-sciences applications, leveraging chlorination capabilities at Pratteln and Kokkola.
• Reagents Specialty chemical reagents supplied as part of CABB's fine chemicals portfolio for use in synthesis and industrial chemistry applications.

Quantifiable outcome

• Plants cover production capacities of up to several thousand tons per substance per year
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

Three partnerships are on record, tiered core, minor and strategic.

• Univar SolutionscoreChannel Partner/ Reseller/ Distributor · 1 February 2026Exclusive distribution partnership through Univar Solutions' Ingredients + Specialties division to distribute GLYCOS Clear 70 and GLYTECH Basic 70 glycolic acid products across select European, Middle Eastern, and African markets covering 32 countries including Germany, France, UK, UAE, Saudi Arabia. Targets personal care, home care, and industrial cleaning applications. CABB gains extended product availability through Univar's distribution network leveraging their market reach and technical expertise. Partnership aims to expand ingredient access regionally.
• Anupam Rasayan India Ltd.minorOthers · 1 January 2026CABB completed the sale of Jayhawk Fine Chemicals Corporation to Anupam Rasayan India Ltd. in 2026. The US site in Galena, Kansas was divested to sharpen CABB's strategic focus. Previously acquired in 2018 as part of CABB's expansion strategy.
• Origin by OceanstrategicStrategic or Co-development Partner · 1 June 2025Strategic partnership to establish a first-in-kind algae biorefinery at CABB's site in Kokkola Industrial Park, Finland. Uses Origin by Ocean's patented technology to process invasive sargassum seaweed into high-value ingredients such as alginate and fucoidan. Targets markets collectively worth $220 billion including cosmetics and detergents. Plans to expand by building biorefineries in Caribbean Sea near where up to 40 million tonnes per year of sargassum blooms cause disruption to tourism and local industry.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• WeylChem International: German-headquartered fine chemicals CDMO with multi-step custom synthesis and complex chemistries, serving agrochemical and life sciences customers — directly comparable to CABB's core offering.
• Saltigo (Clariant): Specialty custom synthesis CDMO within Clariant focused on complex multi-step chemistry for agro and pharma — overlaps with CABB's crop sciences and life sciences business.
• Dottikon Exclusive Synthesis: Swiss fine chemicals CDMO specializing in hazardous multi-step synthesis, intermediates and APIs — close functional peer to CABB's Pratteln and German sites.
• Anupam Rasayan India: Indian specialty chemicals manufacturer and custom synthesis provider that acquired CABB's Jayhawk subsidiary; comparable in agro and pharma intermediate chemistries.

Emerging players

• Hikal: Indian CDMO serving crop sciences and pharmaceuticals with custom synthesis capabilities — overlapping in agro intermediates but generally smaller-scale than CABB.

Broad incumbents

• Lanxess: German specialty chemicals incumbent with custom synthesis, intermediates and fine chemistry — broader portfolio but overlapping chemistries (chlorination, oxidation) relevant to CABB's customer set.
• Evonik Industries: Large German specialty chemicals company with custom synthesis and intermediates across agro, pharma and cosmetics — comparable chemistry breadth and named CABB customer relationship.
• Lonza Group: Global leader in CDMO services including APIs and drug product — comparable as a custom manufacturing peer but operating at much larger scale and with full GMP capabilities CABB lacks.
• Cambrex: CDMO focused on small molecule APIs and intermediates for pharma — directly comparable chemistry scope but with a GMP-centric positioning CABB does not currently match.
• Johnson Matthey: Specialty chemicals and catalyst manufacturer with fine chemistry exposure in pharma and agro — broader portfolio but shares overlap in complex intermediate chemistry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInch.linkedin.com/company/cabb-chemicals

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries11 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CABB